ストックスクリーナーアプリを入手
1.50
10.71%
-0.18
プレマーケット:
1.50
Sana Biotechnology Inc (SANA) 最新ニュース
Levi & Korsinsky Notifies Sana Biotechnology, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSANA - ACCESS Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - GuruFocus
Sana Biotechnology stock hits 52-week low at $1.51 - Investing.com
Levi & Korsinsky Notifies Sana Biotechnology, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – SANA - GlobeNewswire
Levi & Korsinsky Notifies Sana Biotechnology, Inc. Investors of a Class Action Lawsuit and ... - Bluefield Daily Telegraph
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sana Biotechnology, Inc.(SANA) Shareholders - PR Newswire
SANA Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Sana Biotechnology, Inc. Class Action - ACCESS Newswire
Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana ... - Bluefield Daily Telegraph
Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana Biotechnology, Inc. (SANA) - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
SANA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
The Gross Law Firm Notifies Sana Biotechnology, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSANA - Morningstar
Shareholders that lost money on Sana Biotechnology, Inc.(SANA) should contact Levi & Korsinsky about pending Class ActionSANA - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA - TradingView
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - PR Newswire
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for InvestorsContact Levi & Korsinsky - PR Newswire
Bank of New York Mellon Corp Acquires 9,905 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Seattle biotech firm faces investor lawsuit over alleged misleading statements - The Business Journals
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery – ... - Bluefield Daily Telegraph
Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action Lawsuit Against SANA - The National Law Review
Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action - Bluefield Daily Telegraph
Investors in Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Sana Biotechnology, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP Before May 20, 2025 to Discuss Your Rights – SANA - MSN
Shareholders that lost money on Sana Biotechnology, Inc. - GlobeNewswire
No Stopping Sana Biotechnology Inc (NASDAQ: SANA)’s Stock Plunged? - Stocks Register
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - ACCESS Newswire
Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421 - Seeking Alpha
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire
Seattle Biotech Duped Investors On Drug Progress, Suit Says - Law360
Investor Alert: Robbins LLP Informs Investors of the Sana Biotechnology, Inc. Class Action Lawsuit - The Eastern Progress Online
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
SANA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Sana Investor Says It Hid Low Cash Before Record Stock Selloff - Bloomberg Tax
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Sana Biotechnology, Inc. (SANA) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - TradingView
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sana Biotechnology, Inc. (SANA) - TradingView
Research Analysts Set Expectations for SANA Q1 Earnings - Defense World
Sana Biotechnology (NASDAQ:SANA) Stock Rating Upgraded by Citizens Jmp - The AM Reporter
Sana Biotechnology’s SWOT analysis: stock faces pivotal year amid strategic shift By Investing.com - Investing.com South Africa
Sana Biotechnology’s SWOT analysis: stock faces pivotal year amid strategic shift - Investing.com
Sana Biotechnology’s (SANA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Sana Biotechnology (NASDAQ:SANA) Upgraded to Outperform at Citizens Jmp - Defense World
Sana Biotechnology Faces Uncertainty as Financial Struggles Threaten Future Operations - TipRanks
Sana Biotechnology (NASDAQ:SANA) Sees Unusually-High Trading Volume After Strong Earnings - Defense World
Citizens Capital Markets Upgrades Sana Biotechnology (SANA) - Nasdaq
Sana Biotechnology stock upgraded at Citizens (SANA:NASDAQ) - Seeking Alpha
Sana Biotechnology upgraded at Citizens on valuation - MSN
Sana stock holds $11 target post-positive trial update By Investing.com - Investing.com Canada
Sana Biotech stock rating upgraded to Market Outperform By Investing.com - Investing.com UK
Sana Biotechnology Reports 2024 Financial Results and Progress - TipRanks
Sana: Q4 Earnings Snapshot - mySA
Sana Biotechnology shares rise on narrower-than-expected loss By Investing.com - Investing.com South Africa
3.89%
0.13%
大文字化:
|
ボリューム (24 時間):